Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01197612Phase 3Completed
Phase 3, randomised, open-label trial of budesonide in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by University of Michigan. Primary endpoint: Olfaction at 3 weeks. Started Sep 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01197612.